Cytokinetics (CYTK) Non Operating Income (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Non Operating Income of $11.0 million for Q1 2026, down 19.55% year-over-year from $13.7 million in Q1 2025, and down 3.91% quarter-over-quarter from $11.5 million in Q4 2025.
Cytokinetics (CYTK) Non Operating Income (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Non Operating Income for 17 consecutive years, with $11.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income fell 19.55% year-over-year to $11.0 million; the TTM figure through Mar 2026 stood at $45.7 million (down 20.2% YoY), while the FY2025 annual figure was $48.4 million, down 6.04% from the prior year.
- Non Operating Income declined to $11.0 million in Q1 2026 per CYTK's latest filing, from $11.5 million in the prior quarter.
- Across five years, Non Operating Income topped out at $17.1 million in Q3 2024 and bottomed at $415000.0 in Q1 2022.
- Historically, Non Operating Income has averaged $8.8 million across 5 years, with a median of $7.9 million in 2024.
- Annual changes were most pronounced in 2022 — Non Operating Income jumped 1693.94% — and 2025, when it plunged 39.91%.
- Cytokinetics' Non Operating Income stood at $5.9 million in 2022, then grew by 28.16% to $7.6 million in 2023, then surged by 97.92% to $15.0 million in 2024, then decreased by 23.6% to $11.5 million in 2025, then slipped by 3.91% to $11.0 million in 2026.
- Business Quant data shows CYTK's Non Operating Income at $11.0 million in Q1 2026, $11.5 million in Q4 2025, and $10.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.94 Mn |
| Mar 31, 2026 | 11.02 Mn |
| Dec 31, 2025 | 11.47 Mn |
| Sep 30, 2025 | 10.25 Mn |
| Jun 30, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.70 Mn |
| Dec 31, 2024 | 15.01 Mn |
| Sep 30, 2024 | 17.05 Mn |
| Jun 30, 2024 | 11.55 Mn |
| Mar 31, 2024 | 7.91 Mn |
| Dec 31, 2023 | 7.59 Mn |
| Sep 30, 2023 | 6.84 Mn |
| Jun 30, 2023 | 6.78 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 864,000.00 |
| Mar 31, 2022 | 415,000.00 |
| Dec 31, 2021 | -377,000.00 |
| Sep 30, 2021 | 231,000.00 |